Navigation Links
Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008
Date:7/14/2008

tuximab in combination with docetaxel in advanced breast cancer patients. The results showed that bavituximab achieved the pre-specified stage 1 primary endpoint in this trial. Of 14 evaluable patients, seven achieved partial tumor responses and seven had stable disease at week eight according to RECIST criteria. None showed tumor progression during this period.

-- In July 2008, Peregrine announced that it entered into a five-year contract worth up to $44.4 million to test and develop bavituximab and an equivalent fully human antibody as potential broad spectrum treatments for viral hemorrhagic fever infections. The initial contract was awarded through the Transformational Medical Technologies Initiative of the U.S. Department of Defense's Defense Threat Reduction Agency.

-- In June 2008, Peregrine announced that patient screening and dosing had begun in a Phase II trial designed to evaluate the safety and efficacy of bavituximab in combination with carboplatin and paclitaxel in patients with the form of lung cancer know as NSCLC, which is the most commonly occurring cancer in both men and women and lacks effective treatment.

-- In March 2008, Peregrine announced a clinical update on its Cotara program for the treatment of glioblastoma multiforme (GBM), covering the first cohort of patients in its dosimetry trial as well as experience to date in an ongoing Phase II safety and efficacy trial. Cotara appeared to be safe and well tolerated in these brain cancer patients. Several patients who are continuing in the trials have already surpassed the expected median survival time for relapsed GBM patients.

-- In February 2008, Peregrine announced that patient dosing had begun in its first Phase II bavituximab trial. This clinical trial is designed to evaluate the safety and efficacy of bavituximab in combination with chemotherapy in patients with advanced breast cancer.

-- In November 2007 at the prestigious AASLD meeting, Peregrine repor
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Peregrine Pharmaceuticals Awarded DTRA Contract Worth up to $44.4 Million to Develop Bavituximab for Viral Hemorrhagic Fevers
2. Peregrine Pharmaceuticals Presents Promising Phase I Data at ASCO and Provides Clinical Update on Its Phase II Bavituximab Breast Cancer Study
3. Peregrine Pharmaceuticals Reports Studies Published in Science Highlight Key Role of Phosphatidylserine (PS) in Viral Infections
4. Peregrine Pharmaceuticals Announces Four Upcoming Presentations at the American Association for Cancer Research 2008 Annual Meeting
5. Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008
6. Peregrine Pharmaceuticals to Announce Third Quarter FY 2008 Financial Results
7. Publication in Clinical Cancer Research Confirms Ability of Peregrines Bavituximab to Target Tumor Blood Vessels with Excellent Specificity
8. Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer
9. Peregrine Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
10. Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008
11. Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2014)... , July 18, 2014  On ... highlighting AbbVie and Shire,s complementary fit and ... A copy of the infographic materials ... http://www.abbvieinvestor.com/phoenix.zhtml?c=251551&p=irol-disclaimer-documents In accordance ... a copy of this announcement will be ...
(Date:7/18/2014)... MA (PRWEB) July 18, 2014 Provia ... to its growing Advisory Board. Dr. Vaught has ... for over 20 years. As one of the ... Biological and Environmental Repositories - in 1999, he served ... is again president-elect. , In 2005, Dr. Vaught began ...
(Date:7/17/2014)... 17, 2014  Prana Biotechnology (NASDAQ: PRAN ... its clinical development program for Alzheimer,s disease. ... Neuroscience and Mental Health, The University of Melbourne, will ... EURO trials in his presentation at the Alzheimer,s Association ... The presentation is entitled: "How to ...
(Date:7/17/2014)... the design and development of new, more efficient solar ... Berkeley National Laboratory (Berkeley Lab) have developed the first ... model free of adjustable or empirical parameters for ... carriers are electrical charge carriers - electrons and holes ... thermal equilibrium. , "Hot carrier thermalization is a major ...
Breaking Biology Technology:NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 2NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 3NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 4NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 5NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 6NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 7Dr. Jim Vaught, Ph.D., Former Chief of BBRB, Joins Provia Laboratories as Advisory Board Member 2Dr. Jim Vaught, Ph.D., Former Chief of BBRB, Joins Provia Laboratories as Advisory Board Member 3Prana Alzheimer's disease Development Program update 2Prana Alzheimer's disease Development Program update 3Prana Alzheimer's disease Development Program update 4Prana Alzheimer's disease Development Program update 5First ab initio method for characterizing hot carriers 2First ab initio method for characterizing hot carriers 3
... If you have a creative idea or invention, or you ... want to protect, the first thing you do is contact ... that you have protected your invention, so you're set, right? ... sage advice: look both ways before you cross the street, ...
... a private research center south of Madison, a group ... to talk about the ethical choices presented by biotechnology's ... forum will be the memory of Terri Schiavo. , ... questions surrounding patients such as Schiavo, the brain-damaged Florida ...
... seems like there's always one person in a crowd who ... obituaries. Not me. I'm compulsive about reading the job classifieds. ... to fathom the difference between the ubiquitous "excellent communication skills" ... them a quick scan every day, even if it happens ...
Cached Biology Technology:Five patent tips for start-up companies 2Five patent tips for start-up companies 3Schiavo's death calls attention to ethical issues weighed at Bioethics Forum 2Schiavo's death calls attention to ethical issues weighed at Bioethics Forum 3Is IT leadership a position or an attitude? 2Is IT leadership a position or an attitude? 3
(Date:7/21/2014)... A team of University of California, Riverside Bourns ... placed under the grates of a backyard grill reduces by ... cooking. , The one-eighth inch thick steel carbon plate with ... by cutting a slit into the grill to allow the ... be adopted by grill manufacturers who could sell new grills ...
(Date:7/21/2014)... at the INRS nergie Matriaux Tlcommunications Research Centre ... and temporal resolution greatly exceeding that obtained to ... laser source to shoot a molecular movie of ... article presenting the advancement was recently published in ... , "The approach we developed combines multiphoton ionization ...
(Date:7/21/2014)... meat contributes to climate change, due to greenhouse gasses ... are on the rise and that beef cattle are ... types of animals. It is published by Climactic ... gas when it comes to climate change. It is ... the greatest portion of greenhouse gas totals. But methane ...
Breaking Biology News(10 mins):Catching grease to cut grill pollution 2Climate: Meat turns up the heat 2
... This press release is available in Spanish . ... del Mar) have proven that the absence of the 14-3-3 ... these cells, capacity to activate the signalling of a protein ... activation of NF-kB in tumours was also identified as the ...
... Biochemists at the University of California, Riverside report a new ... twins and even triplets in plant seeds. Daniel ... an associate research biochemist in the Department of Biochemistry ... a naturally occurring enzyme that recycles vitamin C in plants ...
... Calif. The University of California, Riverside is hosting the ... through June 22, 2012. Held this year at the ... oral presentations and 130 poster presentations. Because research papers on ... the rate of more than 2000 per year, the workshop, which ...
Cached Biology News:A new indicator for breast cancer relapse identified 2Link between vitamin C and twins can increase seed production in crops 2Link between vitamin C and twins can increase seed production in crops 315th Vitamin D Workshop begins tomorrow 215th Vitamin D Workshop begins tomorrow 3
...
Recombinant Rat Leptin, CF...
Adhesive seal-tab, for HybriWell™ hybridization sealing system *set of 400*...
... The CultureWell cell culture systems provide ... cells for staining and imaging. Each ... with standard optical-quality coverslips in cell ... provided sterile and ready to use. ...
Biology Products: